Dendritic Cell-Based Immunotherapeutics: An Automated Solution to Manufacturing Personalized Medicines

摘要

Personalized medicine represents a revolutionary concept for bringing safer, more targeted therapeutic agents to market. Whether tailored for individual patients or patient subpopula-tions, personalized drugs, cell-based therapeutics, and gene therapies will be able to target specific disease characteristics and pinpoint disease mechanisms in a particular patient, offering the potential for greater efficacy, earlier interventions, reduced risk of off-target drug effects, and new possibilities for satisfying unmet medical needs.